Achieve Life Sciences Inc
Ownership
Ownership Structure
Who owns Achieve Life Sciences Inc (ACHV)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 72.6% of the shares are freely tradable; institutional investors hold 61.0%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| venBio Partners LLC | 5.75 | 5,914,720 | +0.0 | 06/30/2026 |
| Logos Global Management LP | 5.27 | 5,425,000 | +0.0 | 06/30/2026 |
| Paradigm Biocapital Advisors LP | 4.81 | 4,951,856 | +0.0 | 06/30/2026 |
| Franklin Templeton Inc | 4.25 | 4,369,193 | +0.0 | 03/31/2026 |
| Propel Bio Management LLC | 3.92 | 4,034,018 | +6.5 | 06/30/2026 |
| Vivo Capital, LLC | 2.67 | 2,751,032 | +0.0 | 06/30/2026 |
| Eventide Asset Management, LLC | 2.16 | 2,220,000 | +0.0 | 06/30/2026 |
| Vanguard Capital Management, LLC | 2.14 | 2,204,714 | +0.0 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 3.02 | 3,108,369 | +0.0 | 07/31/2026 |
| Eventide Healthcare & Life Sciences I | 2.16 | 2,220,000 | +0.0 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Stewart Richard Alistair | Director | 208,249 | 1,645,167 $ | Aug 19, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 19, 2026 | Stewart Richard Alistair | Director | Sell | 20,626 | 8.49 | 175,177 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.